These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9031265)

  • 1. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
    Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
    Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation.
    Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Todoroki K; Fukao K; Koyama A; Akaza H
    Nephron; 2001 Jun; 88(2):144-8. PubMed ID: 11399917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
    Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM
    Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience.
    Satoh S; Sugimura J; Omori S; Seino K; Fujizuka I
    Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
    Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
    Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic deoxyspergualin treatment in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplantation; 2003 Jan; 75(1):60-6. PubMed ID: 12544872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
    Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
    Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.
    Alexander JW; Babcock GF; First MR; Davies CB; Madden RL; Munda R; Penn I; Fidler JP; Cofer BR; Stephens G
    Transplantation; 1992 Feb; 53(2):423-7. PubMed ID: 1371197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatched living, related donor renal transplantation: a prospective, randomized study.
    Sommer BG; Ferguson RM
    Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
    Sakagami K; Saito S; Shiozaki S; Fujiwara T; Haisa M; Niguma T; Kusaka S; Uda M; Matsuno T; Takasu S
    Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term graft outcome of living donor renal transplantation: single center experience.
    Kwon OJ; Kim YH; Ahn BK; Kang CM; Kwak JY
    Transplant Proc; 2005 Mar; 37(2):690-2. PubMed ID: 15848503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants.
    van der Heide JJ; Bilo HJ; Donker JM; Wilmink JM; Tegzess AM
    N Engl J Med; 1993 Sep; 329(11):769-73. PubMed ID: 8350886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.